India's regulator clears Sun Pharma-Ranbaxy deal

MUMBAI (Reuters) - India's antitrust regulator approved generic drugmaker Sun Pharmaceutical Industries' $3.2 billion bid to buy Ranbaxy Laboratories, but ordered the firms to divest seven products...